true
This amendment is being filed to comply with regulations.
0000945617
false
false
false
false
false
0000945617
2024-11-08
2024-11-08
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
SECURITIES AND
EXCHANGE COMMISSION
FORM 8-K/A
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of
the Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported): November
8, 2024
AMERICAN
CANNABIS COMPANY, INC.
(Exact Name of Registrant
as Specified in its Charter)
Delaware
(State
or other jurisdiction of incorporation or organization) |
Commission
File Number
000-26108 |
90-1116625
(I.R.S.
Employer
Identification
Number) |
1004
S Tejon St Colorado
Springs, CO
80903
(Address of
Principal Executive Offices and Zip Code)
(303)
974-4770
(Issuer's telephone
number)
(Former Name
or Former Address, if Changed Since Last Report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[
] Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[
] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[
] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[
] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
Trading Symbols |
Name of Exchange on Which Registered |
Common |
AMMJ |
None |
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2
of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company [
]
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 1.01 Entry into a Material Definitive
Agreement
On November 20, 2024, the Board of Directors
of American Cannabis Company, Inc. (the “Company”) approved entry into the following material definitive agreements:
1. Binding
Letter of Intent
The Company entered into a binding Letter of
Intent (“LOI”) with Credex Corp. Under the terms of the LOI, the Company will acquire all of Credex's assets and assume certain
mutually agreed-upon debts. The LOI obligates the Company to perform due diligence and negotiate and execute material definitive agreements,
which will be subject to further independent determination and approval. The proposed transaction aligns with the Company’s strategic
goals and will be disclosed in detail in subsequent filings upon execution of the definitive agreements.
2. Services
Contract with Joseph Cleghorn
Concurrently, the Company entered into a services
contract with Joseph Cleghorn, who was recently appointed Chief Executive Officer, interim Chief Financial Officer, and Director. Under
the contract, Mr. Cleghorn will serve in these roles for a one-year term. Notably, the contract stipulates that no cash or equity consideration
will be provided, reflecting a favorable arrangement for the Company and its shareholders.
Item 5.02 Departure of Directors or Principal
Officers; Election of Directors; Appointment of Principal Officers
Effective November 11, 2024, the Company appointed
Mr. Joseph Cleghorn as Chief Executive Officer, interim Chief Financial Officer, and Director. Mr. Cleghorn’s appointment was disclosed
in the Form 8-K, filed on November 8, 2024. The approval of his services contract, as outlined above, further formalizes his roles, responsibilities,
and compensation.
Section 9 – Financial Statements and
Exhibits
Item 9.01 Financial Statements and Exhibits
Exhibit Index:
Exhibit Number Description
10.1 Binding LOI (filed herewith)
10.2 Contract with Joseph Cleghorn (filed herewith)
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated
November 21, 2024
AMERICAN CANNABIS COMPANY, INC.
(Registrant)
By: /s/ Joseph Cleghorn
Joseph Cleghorn
Chief Executive Officer
Principal Executive Officer
Exhibit
10.1
BINDING
LETTER OF INTENT
This
Binding Letter of Intent (“LOI”) sets forth the principal terms and conditions under which American Cannabis Company, Inc.
(“ACC” or the “Buyer”), a Delaware corporation, intends to acquire substantially all of the assets and debts
of Credex Corp. (“Credex” or the “Seller”), a Florida corporation, subject to the execution of definitive transaction
documents.
| (a) | Assets
to be Acquired: The buyer intends to acquire all tangible and intangible assets of Credex,
including, but not limited to, intellectual property, contracts, licenses, inventory, equipment,
goodwill, and any other assets identified during due diligence. |
| (b) | Assumed
Debts: The buyer will assume certain specified debts and liabilities of Credex, as listed
in an agreed-upon Schedule of Assumed Liabilities. |
| (c) | Excluded
Assets and Liabilities: The definitive agreement will identify and exclude any excluded
assets or liabilities. |
The
total consideration for the transaction (the “Purchase Consideration”) will be determined through mutual agreement during
the due diligence and negotiation process. The structure of the Purchase Consideration may include, but is not limited to:
| (a) | Cash
Payment: An agreed-upon cash amount payable at closing; |
| (b) | Equity
Issuance: Shares of ACC common stock or other securities issued to Credex or its shareholders; |
| (c) | Assumption
of Liabilities: An allocation of assumed debts and obligations of Credex; and/or |
| (d) | Other
Consideration: Any additional forms of compensation to be negotiated in good faith. |
The precise
allocation and form of the Purchase Consideration will be outlined in the definitive agreements following the conclusion of due diligence.
The Buyer
shall have a period of 60 days from the date of this LOI to conduct financial, operational, legal, and regulatory due diligence of Credex.
The Seller shall provide full access to all necessary documents, records, and personnel to facilitate this process.
The Parties
shall negotiate in good faith to execute definitive transaction documents, including but not limited to:
| (a) | Asset
Purchase Agreement; |
| (b) | Assignment
and Assumption Agreement; |
| (d) | Ancillary
Agreements (as required); |
| (e) | SEC
filings (as required). |
The obligations
of the Parties to complete the transaction shall be subject to customary conditions, including but not limited to:
| (a) | Buyer’s
satisfactory completion of due diligence; |
| (b) | Necessary
approvals from each Party’s board of directors and shareholders (if applicable); |
| (c) | Receipt
of all required regulatory and third-party consents. |
The following
provisions are intended to be binding and enforceable:
| (a) | Exclusivity:
Credex agrees not to engage in discussions or negotiations with any other party concerning
the sale of its assets or debts during the exclusivity period of [XX] days. |
| (b) | Confidentiality:
Both Parties agree to maintain the confidentiality of all information exchanged during the
negotiation and due diligence process. |
| (c) | Governing
Law: This LOI shall be governed by and construed in accordance with the laws of the State
of Colorado. |
| (d) | Expenses:
Each Party shall bear its own expenses incurred in connection with this LOI and the transaction. |
This LOI
shall terminate upon the earlier of:
| (a) | Execution
of definitive agreements; |
| (b) | Expiration
of the exclusivity period; or |
| (c) | Mutual
written agreement of the Parties. |
Except for
the binding provisions set forth in Section 6, this LOI is not intended to create any binding obligation for either Party to consummate
the transaction described herein until the execution of definitive agreements.
For American Cannabis
Company, Inc.:
By: /s/
Ellis Smith
Name:
Ellis Smith
Title:
Director
Date:
11/20/2024
For Credex Corp.:
By:
/s/ Joseph Cleghorn
Name: Joseph Cleghorn
Title:
Chairman of the Board
Date:
11/20/24
Exhibit
10.2
Contents
Article
I. Term of Employment. |
1 |
Article
II. Duties and Obligations of Employee. |
1 |
Article
III. Obligations of Employer. |
3 |
Article
IV. Compensation of Employee. |
3 |
Article
V. Employee Benefits. |
3 |
Article
VI. Business Expenses. |
3 |
Article
VII. Termination of Employment. |
3 |
Article
VIII. Non-Competition and Non-Solicitation. |
4 |
Article
IX. Representation of Employee. |
5 |
Article
X. General Provisions. |
5 |
Senior
Executive Employment Contract
Employment Contract
for Director, Chief Executive Officer, Chief Financial Officer
This Employment
Agreement (“Agreement”) is entered into this November 20, 2024 (the “Effective Date”) between American
Cannabis Company, Inc. ("Employer"), a Delaware corporation located at 1004 S. Tejon Street, Colorado Springs, CO, 80903,
and Joseph Cleghorn ("Employee"), with a residence at 701 Waddell Avenue, Key West, FL 33040; Employer and Employee
are collectively the “Parties.”
In consideration of the mutual
promises made herein, the Parties agree as follows:
Article
I. Term of Employment.
Specified Term
Section
1.1. The Employer employs the Employee, who accepts employment with the Employer for one year,
beginning on November 11, 2024, and terminating on November 11, 2025.
Earlier Termination
Section 1.2.
This Agreement may be terminated earlier as hereinafter provided.
Article
II. Duties and Obligations of Employee.
Title and Description of Duties
Section
2.1. Employee shall serve as Director, Chief Executive Officer, and Chief Financial Officer of
the Employer. In that capacity, the Employee shall do and perform all services, acts, or things necessary or advisable to fulfill the
duties of a Director, Chief Executive Officer, and Chief Financial Officer. However, in his capacity as Chief Executive Officer and Chief
Financial Officer, the Employee shall always be subject to the direction and policies established by the Board of Directors of Employer.
Loyal and Conscientious Performance
of Duties
Section
2.2. Employee agrees that to the best of his ability and experience, he will at all times loyally
and conscientiously perform all of the duties and obligations required of him either expressly or implicitly by the terms of this Agreement.
Devotion of Time to Employer's
Business
Section 2.3.
| (a) | Employee
shall devote his productive time, ability, and attention to the business of Employer during
the term of this Agreement. |
| (b) | During
the term of this Agreement, Employee shall not engage in any other business duties or pursuits
that pose a conflict of interest to the Employer or the Employer’s business. Furthermore,
during the term of this Agreement, Employee shall not, whether directly or indirectly, render
any services of a commercial or professional nature to any other person or organization,
whether for compensation or otherwise, without the prior written consent of Employer's President,
which shall not be unreasonably withheld. However, the expenditure of reasonable amounts
of time for educational, charitable, or professional activities shall not be deemed a breach
of this section if those activities do not materially interfere with the services required
under this Agreement and shall not require the prior written consent of Employer. |
| (c) | This
Agreement shall not be interpreted to prohibit Employee from making passive personal investments
or conducting private business affairs if those activities do not materially interfere with
the services required under this Agreement. However, Employee shall not, directly or indirectly,
acquire, hold, or retain any interest in any business competing with or similar in nature to the business of Employer. |
Competitive
Activities
Section
2.4. During the term of this contract, Employee shall not, directly or indirectly, either as
an employee, employer, consultant, agent, principal, partner, stockholder, corporate officer, director, or in any other individual or
representative capacity, engage or participate in any business that is in competition in any manner whatsoever with the business of Employer.
Uniqueness
of Employee's Services
Section
2.5. Employee represents and agrees that the services to be performed under the terms of this
Agreement are of a special, unique, unusual, extraordinary, and intellectual character that gives them a peculiar value, the loss of
which cannot be reasonably or adequately compensated in damages in action at law. Employee, therefore, expressly agrees that Employer,
in addition to any other rights or remedies that Employer may possess, shall be entitled to seek injunctive and other equitable relief
to prevent or remedy a breach of this Agreement by Employee.
Indemnification for Negligence
or Misconduct
Section
2.6. Employee shall indemnify and hold Employer harmless from all liability for loss, damage,
or injury to persons or property resulting from Employee's negligence or misconduct.
Trade Secrets
Section 2.7.
| (a) | The
Parties acknowledge and agree that during the term of this Agreement and in the course of
the discharge of his duties hereunder, Employee shall have access to and become acquainted
with financial, personnel, sales, scientific, technical and other information regarding formulas,
patterns, compilations, programs, devices, methods, techniques, operations, plans and processes
that are owned by Employer, actually or potentially used in the operation of Employer's business,
or obtained from third parties under an agreement of confidentiality, and that such information
constitutes "Employer's Trade Secrets." |
| (b) | Employee
specifically agrees that he shall not misuse, misappropriate, or disclose in writing, orally
or by electronic means, any Trade Secrets, directly or indirectly, to any other person or
use them in any way, either during the term of this Agreement or at any other time thereafter,
except as is required in the course of his employment for Employer. |
| (c) | Employee
acknowledges and agrees that the sale or unauthorized use or disclosure in writing, orally
or by electronic means, of any of Employer's Trade Secrets obtained by Employee during the
course of his employment under this Agreement, including information concerning Employer's
actual or potential work, services, or products, the facts that any such work, services,
or products are planned, under consideration, or in production, as well as any descriptions
thereof, constitute unfair competition. Employee promises and agrees not to engage in any
unfair competition with Employer, either during the term of this Agreement or at any other
time thereafter. |
| (d) | Employee
further agrees that all files, records, documents, drawings, specifications, equipment, software,
and similar items, whether maintained in hard copy or online relating to Employer's business,
whether prepared by Employee or others, are and shall remain exclusively the property of
Employer and that they shall be removed from the premises or, if kept on-line, from the computer
systems of Employer only with the express prior written consent of Employer's Board of Directors. |
Article
III.
Obligations of Employer.
General Description
Section 3.1.
Employer shall provide Employee with the compensation, incentives, benefits, and business expense reimbursement as specified in this
Agreement.
Office and Staff
Section 3.2.
The Employer shall provide the Employee with business equipment, office space, and administrative support suitable to the Employee's
position and adequate for performing his duties.
Article
IV. Compensation of Employee.
Annual Salary
Section
4.1. Employee waives payment of compensation for the term of this Agreement.
Article
V. Employee Benefits.
Health Insurance
Section
5.1. The Employer agrees to reimburse the Employee for the premiums of the Employee’s current
health insurance plan upon the Employee’s submission of premium statements to the Employer.
Life Insurance
Section
5.2. The Employer agrees to reimburse the Employee for the premiums of the Employee’s current
life insurance policy upon the Employee’s submission of premium statements to the Employer.
Article
VI. Business Expenses.
Business Expenses
Section
6.1.
| (a) | Employer
shall promptly reimburse Employee for all reasonable business expenses incurred by Employee
in promoting the business of Employer, including expenditures for entertainment, gifts, and
travel. |
| (b) | Each
such expenditure shall be reimbursable only if it is of a nature qualifying it as a proper
deduction on the federal and state income tax return of Employer. |
| (c) | Each
such expenditure shall be reimbursable only if Employee furnishes to Employer adequate records
and other documentary evidence required by federal and state statutes and regulations issued
by the appropriate taxing authorities for the substantiation of that expenditure as an income
tax deduction or as may be required by Employer. |
Article
VII. Termination of Employment.
Termination for Cause
Section 7.1.
| (a) | Employer
reserves the right to terminate this Agreement if Employee (1) willfully breaches or habitually
neglects the duties which he is required to perform under the terms of this Agreement, or
(2) commits acts of dishonesty, fraud, misrepresentation, or other acts of moral turpitude,
that would prevent the effective performance of his duties. |
| (b) | Employer
may, at its option, terminate this Agreement for the reasons stated in this section by giving
written notice of termination to Employee without prejudice to any other remedy to which
Employer may be entitled either at law, in equity, or under this agreement. |
| (c) | Termination
under this section shall be considered "for cause" for the purposes of this Agreement. |
Termination Without Cause
Section
7.2.
| (a) | This
Agreement shall be terminated upon the death of Employee. |
| (b) | Employer
reserves the right to terminate this Agreement not less than 3 months after Employee suffers
any physical or mental disability that would prevent the performance of his essential job
duties under this Agreement, unless reasonable accommodation can be made to allow Employee
to continue working. Such a termination shall be effected by giving 10 days'] written notice
of termination to Employee. |
| (c) | Termination
under this section shall not be considered "for cause" for the purposes of this
Agreement. |
Effect of Merger, Transfer of Assets,
or Dissolution
Section
7.3.
| (a) | This
Agreement shall not be terminated by any voluntary or involuntary dissolution of Employer
resulting from either a merger or consolidation in which Employer is not the consolidated
or surviving corporation, or a transfer of all or substantially all of the assets of Employer. |
| (b) | In
the event of any such merger or consolidation or transfer of assets, Employer's rights, benefits,
and obligations hereunder shall be assigned to the surviving or resulting corporation or
the transferee of Employer's assets. |
Termination
by Employee
Section
7.4. Employee may terminate his obligations under this Agreement by giving Employer at least
30 days’ notice.
Effect on
Compensation
Section
7.5. If this Agreement is terminated before the completion of the term of employment specified
herein, Employee shall be entitled to the compensation earned by and vested in him prior to the termination date as provided for in this
Agreement, computed pro rata up to and including that date. Employee shall be entitled to no further compensation as of the termination
date.
Article
VIII. Non-Competition and Non-Solicitation.
Section
8.1. Employee agrees that during his employment by the Employer and the one (1) year period commencing
upon termination of his employment (the “Restriction Period”) Employee will not, directly or indirectly: (i) own, manage,
operate, control or participate in the ownership, management, operation of, or be connected as an officer, partner, director or otherwise,
or have any financial interest in any other business that is (a) significant to the Employer and its subsidiaries as a whole and (b)
during Employee’s employment hereunder is in competition with the business conducted by the Employer and any of its subsidiaries
in any geographic region where such business is being conducted during such Restriction Period; provided that ownership, for personal
investment purposes only, of no more than five (5) percent of the voting stock of any publicly held corporation shall not constitute
a violation of this section; or (ii) solicit the customers of the Employer and its subsidiaries for business on behalf of any entity or person other than the Employer and its subsidiaries.
Section
8.2. During the Restriction Period, Employee will not, directly or indirectly, solicit for employment
by any person or entity other than the Employer and its subsidiaries, any person then employed by the Employer and its subsidiaries.
Section
8.3. Employee agrees that during the term of this Agreement, he will not take any action which
might divert from the Employer or any of its subsidiaries any opportunity which would be within the scope of any of the present businesses
of Employer or any business proposed or contemplated to be engaged in by Employer during the term of this Agreement.
Article
IX. Representation of Employee.
Section 9.1.
Employee represents and warrants that Employee’s employment with Employer and performance under this Agreement will not violate
or breach any duty or obligation owed by Employee to any other person or company under contract, agreement or by operation of law.
Article
X. General Provisions.
Notices
Section 10.1.
Any notices required to be given under this Agreement by either party to the other shall be in writing and shall be transmitted either
by (i) registered mail, (ii) certified mail, return receipt requested, or (iii) overnight mail, addressed to the party to be notified
at the following address or to such other address (or person) as such party shall specify by like notice hereunder:
American
Cannabis Company, Inc. |
Joseph
Cleghorn |
1004
S. Tejon Street, Colorado Springs, CO 80903 |
701
Waddell Avenue, Key West, FL 33040 |
Attention:
Ellis Smith, Director |
Attention:
Joseph Cleghorn |
Arbitration
Section
10.2. Any dispute, controversy, or claim between the Parties arising out of or related in any way to this Agreement which
cannot be amicably resolved by the Parties shall be solely and finally settled by arbitration administered by JAMS following its commercial
arbitration rules. Judgment on the award rendered by the arbitrator(s) may be entered in any court having jurisdiction thereof. The arbitration
shall occur before a panel of three arbitrators in Denver, Colorado. The arbitration shall be in English. The arbitrators will be bound
to adjudicate all disputes following the laws of the State of Colorado. The arbitrators' decision shall be in writing with written findings
of fact and shall be final and binding on the Parties. Each party shall bear its own costs for the arbitration proceedings irrespective
of its outcome. This section provides the sole recourse for the settlement of any disputes arising out of, in connection with, or related
to this Agreement.
Attorneys' Fees and Costs
Section 10.3.
If either party incurs any legal fees associated with the enforcement of this Agreement or any rights under this Agreement, the prevailing
party shall be entitled to recover its reasonable attorney’s fees and
any court, arbitration, mediation, or other litigation expenses from the other party.
Entire Agreement
Section
10.4. This Agreement supersedes any and all other agreements, either oral or in writing, between the Parties hereto with
respect to the employment of Employee by Employer and contains all of the covenants and agreements between the Parties with respect to
that employment in any manner whatsoever. Each party to this Agreement acknowledges that no representations, inducements, promises, or
agreements, orally or otherwise, have been made by any party, or anyone acting on behalf of any party, which are not embodied herein,
and that no other agreement, statement, or promise not contained in this Agreement shall be valid or binding.
Modifications
Section
10.5. Any modification of this agreement will be effective only if it is in writing signed by Employee and an authorized
representative of the Employer.
Waiver
Section
10.6. The failure of either party to insist on strict compliance with any of the terms, covenants, or conditions of this
Agreement by the other party shall not be deemed a waiver of that term, covenant, or condition, nor shall any waiver or relinquishment
of any right or power at any one time or times be deemed a waiver or relinquishment of that right or power for all or any other times.
Enforceability
Section
10.7. Employer and Employee recognize that the laws and public policies of the various states of the United States may
differ regarding the validity and enforceability of certain provisions in this Agreement. The Parties intend that all provisions of this
Agreement shall be enforced to the fullest extent permissible under the laws and public policies of each state and jurisdiction in which
such enforcement is sought, and that the unenforceability of any provision hereof shall not render unenforceable or impair the remainder
of the Agreement. Accordingly, if any provision of this Agreement shall be determined to be invalid or unenforceable, then the offending
provision or part thereof shall be deleted as narrowly as possible to render the remaining balance of the Agreement enforceable and to
protect to the fullest extent the Employer’s legitimate interests as expressed and intended herein.
Law Governing Agreement
Section 10.8.
This Agreement shall be governed by and construed following the laws of the State of Colorado, without regard to its conflicts of
laws principles.
Employee Review
Section
10.9. Employee understands that this Agreement creates legally binding obligations and that Employee will be subject
to liability if the Employee violates any of the provisions of this Agreement. The Employee acknowledges having read this Agreement,
having understood the meaning and consequences of every term and enters it voluntarily and freely and after adequate opportunity to review
and consider it and to consult with his legal and financial advisors. Employee acknowledges receiving a copy of this Agreement and that
the consideration received by Employee for entering into this Agreement is fair and equitable.
Survival
Section
10.10. The provisions of this Agreement which by their nature extend beyond the termination of the Agreement will survive termination
or expiration of the Agreement.
Sums Due Deceased
Employee
Section
10.11.
If Employee dies
prior to the expiration of the term of his employment, any sums that may be due him from Employer under this agreement as of the date
of death shall be paid to Employee's executors, administrators, heirs, personal representatives, successors, and assigns.
IT WITNESS WHEREOF, the Parties
have signed this Agreement on November 19, 2024.
EMPLOYER
AMERICAN CANNABIS COMPANY, INC.
By: |
/s/
Ellis Smith |
|
|
ELLIS
SMITH, DIRECTOR |
|
EMPLOYEE
JOSEPH CLEGHORN
By: |
/s/
Joseph Cleghorn |
|
|
JOSEPH
CLEGHORN |
|
v3.24.3
X |
- DefinitionDescription of changes contained within amended document.
+ References
+ Details
Name: |
dei_AmendmentDescription |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14a -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
American Cannabis (CE) (USOTC:AMMJ)
Historical Stock Chart
From Oct 2024 to Nov 2024
American Cannabis (CE) (USOTC:AMMJ)
Historical Stock Chart
From Nov 2023 to Nov 2024